A recent study analyzed the effects of radiofrequency ablation versus stereotactic body radiotherapy in patients with non-surgically managed localized hepatocellular carcinoma.


By Marilynn Larkin

NEW YORK (Reuters Health) - Curative therapies are more likely to be prescribed when liver cancer patients are evaluated by a multidisciplinary team of specialists such as hepatologists, oncologists or surgeons, rather than general gastroenterologists, researchers say.

Read More

By David Douglas

NEW YORK (Reuters Health) - A simplified prognostic score may increase the accuracy of survival prediction after hepatectomy for intrahepatic cholangiocarcinoma (ICC), according to California-based researchers.

Read More

Subscribe to Liver Cancer